Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers.
Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland.
Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 2627 Hanover St, Palo Alto,california 94304,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.avenuebiosciences.com
- Keywords
- Desk Manager jobs.
- HQ
- Palo Alto, California
Avenue Biosciences Questions
Avenue Biosciences's website is http://www.avenuebiosciences.com
Avenue Biosciences's LinkedIn profile is https://www.linkedin.com/company/avenue-biosciences
Avenue Biosciences has
13 employees.
View email and phone details for 13
employees at Avenue Biosciences.
Avenue Biosciences's industry is
Biotechnology Research
Avenue Biosciences's top competitors are
Siteone Therapeutics, Inc.,
Bitterroot Bio,
Aikium Inc.,
Arda Therapeutics,
Signios Biosciences,
Integrated Biosciences, Inc.,
Nucleate Bay Area,
Curve Biosciences,
Bluejay Therapeutics,
Trace Neuroscience.
Avenue Biosciences's categories are Biotechnology Research
Avenue Biosciences's founding year is 2023
